Mental health disorders are also prevalent in American youth; one in five aged 13 to 18 experiences a severe mental health disorder during their lifetime (Merikangas et al., 2010). Additionally, suicide is the third leading cause of death among persons aged 10 to 14, and the second cause of death among persons ages 15 to 34 (Centers for Disease Control and Prevention, 2013).
GROWTH IN THE USE OF PSYCHOTROPICSTreatment for psychiatric conditions, especially the use of psychopharmacologic agents, has grown in recent years in the United States. Approximately one of six adults took a psychiatric drug at least once in 2013, with twofold to threefold increases considering race/ethnicity, age, and sex (Moore & Mattison, 2017). Three psychiatric diagnostic groups are among the top 20 diagnostic categories in primary care settings (i.e., psychoses, excluding major depressive disorder; attention-deficit/hyperactivity disorder; and anxiety states), and antidepressants are the third most prescribed drug class (Hing, Rui, & Palso, 2013). Psychotropic medication use is also common among children and adolescents in the United States. Seven and one-half percent (7.5%) of children and adolescents ages 6 to 17 received medications for behavioral or emotional difficulties in 2011 to 2012 (Howie, Pastor, & Lukacs, 2014). Psychotropic medication prescriptions for noninstitutionalized adolescents increased by fivefold for any psychotropic medication, and were up to Disclaimer: The view(s) expressed herein are those of the author(s)